Discuss risk factors with your provider Combined hormonal contraceptives (those containing estrogen and progestin) come with an increased risk of blood clots
Mounjaro and Wegovy are not interchangeable, so it is not recommended that you switch back and forth regularly, as this could affect your progress
Adding medication changes that curve substantially: Wegovy tablet: 13.6% average weight loss (OASIS 4 trial, 64 weeks) Wegovy injection: 14.9% average weight loss (STEP 1 trial, 68 weeks) Mounjaro Injection: up to 22.5% average weight loss at the highest dose (SURMOUNT-1 trial, 72 weeks) Sources: Wilding et al., NEJM 2021 (STEP 1) Wharton et al., NEJM 2025 (OASIS 4) Jastreboff et al., NEJM 2022 (SURMOUNT-1
Here's the realistic range
Recently, however, there is growing interest in its potential to support metabolism and fat losskey areas of focus for our patients at Vive
In cases of suspected cobalt hypersensitivity, an intradermal test dose should be administered